LS Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.22M | Sell |
50,485
-11,618
| -19% | -$304K | 0.16% | 80 |
|
|
2026
Q1 | $1.74M | Sell |
62,103
-7,218
| -10% | -$192K | 0.26% | 57 |
|
|
2025
Q4 | $1.73M | Sell |
69,321
-12,838
| -16% | -$324K | 0.24% | 58 |
|
|
2025
Q3 | $2.09M | Sell |
82,159
-8,020
| -9% | -$198K | 0.29% | 52 |
|
|
2025
Q2 | $2.19M | Buy |
90,179
+9,727
| +12% | +$227K | 0.32% | 51 |
|
|
2025
Q1 | $2.04M | Sell |
80,452
-14,560
| -15% | -$381K | 0.31% | 52 |
|
|
2024
Q4 | $2.52M | Sell |
95,012
-42,404
| -31% | -$1.15M | 0.37% | 50 |
|
|
2024
Q3 | $3.98M | Sell |
137,416
-1,108
| -0.8% | -$32.3K | 0.59% | 41 |
|
|
2024
Q2 | $3.88M | Buy |
138,524
+12,442
| +10% | +$343K | 0.6% | 41 |
|
|
2024
Q1 | $3.5M | Sell |
126,082
-7,493
| -6% | -$208K | 0.56% | 43 |
|
|
2023
Q4 | $3.85M | Buy |
133,575
+1,386
| +1% | +$41.9K | 0.67% | 38 |
|
|
2023
Q3 | $4.38M | Sell |
132,189
-15,281
| -10% | -$540K | 0.82% | 38 |
|
|
2023
Q2 | $5.41M | Sell |
147,470
-33,707
| -19% | -$1.31M | 0.95% | 39 |
|
|
2023
Q1 | $7.39M | Sell |
181,177
-25,871
| -12% | -$1.12M | 1.37% | 29 |
|
|
2022
Q4 | $10.6M | Sell |
207,048
-14,015
| -6% | -$672K | 2.07% | 13 |
|
|
2022
Q3 | $9.67M | Buy |
221,063
+6,931
| +3% | +$337K | 1.96% | 17 |
|
|
2022
Q2 | $11.2M | Buy |
214,132
+400
| +0.2% | +$20.4K | 2.09% | 11 |
|
|
2022
Q1 | $11.1M | Sell |
213,732
-2,265
| -1% | -$118K | 1.76% | 22 |
|
|
2021
Q4 | $12.8M | Sell |
215,997
-47,137
| -18% | -$2.34M | 1.92% | 18 |
|
|
2021
Q3 | $11.3M | Buy |
263,134
+2,557
| +1% | +$113K | 1.46% | 29 |
|
|
2021
Q2 | $10.2M | Sell |
260,577
-114,097
| -30% | -$4.44M | 1.29% | 29 |
|
|
2021
Q1 | $13.6M | Sell |
374,674
-21,483
| -5% | -$763K | 0.76% | 28 |
|
|
2020
Q4 | $14.6M | Sell |
396,157
-31,924
| -7% | -$1.17M | 0.77% | 24 |
|
|
2020
Q3 | $14.9M | Buy |
428,081
+7,599
| +2% | +$266K | 0.85% | 21 |
|
|
2020
Q2 | $13M | Buy |
420,482
+73,841
| +21% | +$2.51M | 0.81% | 22 |
|
|
2020
Q1 | $10.7M | Sell |
346,641
-7,910
| -2% | -$270K | 0.78% | 26 |
|
|
2019
Q4 | $13.2M | Buy |
354,551
+956
| +0.3% | +$34.1K | 0.71% | 30 |
|
|
2019
Q3 | $12.1M | Sell |
353,595
-19,298
| -5% | -$702K | 0.7% | 29 |
|
|
2019
Q2 | $15.3M | Sell |
372,893
-3,005
| -0.8% | -$119K | 0.93% | 18 |
|
|
2019
Q1 | $15.1M | Sell |
375,898
-8,524
| -2% | -$341K | 0.94% | 17 |
|
|
2018
Q4 | $15.9M | Sell |
384,422
-60,042
| -14% | -$2.49M | 1.11% | 10 |
|
|
2018
Q3 | $18.6M | Sell |
444,464
-10,857
| -2% | -$418K | 1.07% | 11 |
|
|
2018
Q2 | $15.7M | Sell |
455,321
-6,481
| -1% | -$221K | 0.95% | 18 |
|
|
2018
Q1 | $15.6M | Sell |
461,802
-1,262
| -0.3% | -$43.4K | 0.93% | 23 |
|
|
2017
Q4 | $15.9M | Sell |
463,064
-11,309
| -2% | -$386K | 0.93% | 20 |
|
|
2017
Q3 | $16.1M | Sell |
474,373
-14,436
| -3% | -$464K | 0.96% | 20 |
|
|
2017
Q2 | $15.6M | Buy |
488,809
+40,415
| +9% | +$1.27M | 0.95% | 21 |
|
|
2017
Q1 | $14.6M | Sell |
448,394
-40,423
| -8% | -$1.27M | 0.93% | 20 |
|
|
2016
Q4 | $15.1M | Buy |
488,817
+7,293
| +2% | +$223K | 1.06% | 15 |
|
|
2016
Q3 | $15.5M | Buy |
481,524
+25,580
| +6% | +$855K | 1.14% | 16 |
|
|
2016
Q2 | $15.2M | Sell |
455,944
-31,515
| -6% | -$1.01M | 1.05% | 17 |
|
|
2016
Q1 | $13.7M | Buy |
487,459
+4,816
| +1% | +$138K | 1.02% | 17 |
|
|
2015
Q4 | $14.8M | Sell |
482,643
-48,278
| -9% | -$1.52M | 1.15% | 13 |
|
|
2015
Q3 | $15.8M | Buy |
530,921
+6,515
| +1% | +$209K | 1.27% | 12 |
|
|
2015
Q2 | $16.7M | Buy |
524,406
+8,846
| +2% | +$288K | 1.24% | 14 |
|
|
2015
Q1 | $17M | Buy |
515,560
+76,901
| +18% | +$2.44M | 1.3% | 12 |
|
|
2014
Q4 | $13M | Buy |
438,659
+1,632
| +0.4% | +$46.8K | 1.05% | 24 |
|
|
2014
Q3 | $12.3M | Sell |
437,027
-36,304
| -8% | -$1.02M | 1.05% | 26 |
|
|
2014
Q2 | $13.3M | Sell |
473,331
-97,204
| -17% | -$2.77M | 1.13% | 20 |
|
|
2014
Q1 | $17.4M | Sell |
570,535
-17,237
| -3% | -$514K | 1.42% | 12 |
|
|
2013
Q4 | $17.1M | Buy |
587,772
+24,003
| +4% | +$699K | 1.54% | 11 |
|
|
2013
Q3 | $15.4M | Sell |
563,769
-10,143
| -2% | -$276K | 1.85% | 8 |
|
|
2013
Q2 | $15.3M | Buy |
+573,912
| New | +$15.9M | 1.96% | 7 |
|
Other funds holding PFE
CWP
FWIA
ORIO
CNB
LS Investment Advisors's PFE Position: Q2 2026 in Review
LS Investment Advisors reduced its Pfizer (PFE) stake by 19% in Q2 2026, selling an estimated $304K and leaving 50,485 shares worth $1.22M. The position accounts for 0.16% of the portfolio, ranked #80.
LS Investment Advisors first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $18.6M in Q3 2018. 680 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- LS Investment Advisors held 50,485 shares of Pfizer worth $1.22M as of Q2 2026.
- LS Investment Advisors sold 11,618 Pfizer shares in Q2 2026, an estimated $304K.
- Pfizer made up 0.16% of LS Investment Advisors's portfolio in Q2 2026, its #80 holding.
- LS Investment Advisors first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- LS Investment Advisors's Pfizer position peaked at $18.6M in Q3 2018.
- 680 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on LS Investment Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.